Group 1: Mineral Resources Ltd (MIN) - The share price of Mineral Resources Ltd has increased by 11.9% since the beginning of 2025 and is currently 28.6% above its 52-week lows [1] - Mineral Resources Ltd is a diversified mining company focused on lithium and iron ore extraction in Western Australia, and it also provides mining and engineering services through its subsidiary, CSI Mining Services [1][2] - The company differentiates itself from competitors by maintaining in-house engineering and construction capabilities, allowing for greater control and flexibility during product development [2] Group 2: ResMed (RMD) - ResMed, founded in 1989, specializes in medical equipment, particularly cloud-connectable CPAP machines for treating obstructive sleep apnea, and is headquartered in San Diego, California [3][4] - The company operates in over 140 countries with more than 10,000 employees and has two main business units: Sleep and Respiratory Care, and Software as a Service (SaaS) [4] - In the Sleep and Respiratory Care unit, ResMed provides advanced CPAP machines and ventilation solutions, while the SaaS unit offers software supporting durable medical equipment [4] Group 3: Share Price Valuation - Mineral Resources Ltd currently has a price-to-sales ratio of 1.45x, significantly lower than its 5-year average of 3.02x, indicating that shares may be undervalued or that revenue has increased [6] - ResMed shares are trading at a price-to-sales ratio of 5.70x, which is also below its 5-year average of 8.70x, suggesting a similar undervaluation [7]
MIN and Resmed CDI: 2 ASX shares to dig into
Rask Mediaยท2025-09-20 01:57